I personally reckon that a CR will coincide with positive 3rd dose data.
CHM presents at the conference in USA June 3 . this would be timely considering the interest positive news would generate.
Of coarse this is pure conjuncture on my part, just filling in time waiting for the stars to align for chm.
Ann: Completion of Viral Vector Manufacturing for Phase 1 trial, page-14
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable